Beluga Health Review

Beluga Health is the engine, not the storefront

Most of the names on our rankings want your business directly. Beluga Health does not. It is a nationwide white-label telehealth medical group, led by Dr. Jonah Mink, that quietly powers other companies' direct-to-consumer health brands. When you sign up with some glossy weight-loss startup you have never heard of, there is a real chance Beluga's licensed providers and pharmacy logistics are doing the actual clinical work behind the curtain. That makes this a genuinely unusual entry: it is infrastructure, not a product you can buy as an individual. If you are a regular shopper comparing where to get semaglutide or tirzepatide, Beluga is mostly useful to understand, not to enroll with.

There is no consumer price, and that is by design

Beluga does not publish a standard monthly rate because it does not sell to patients. It is a B2B platform that licenses its provider network, legal framework, and pharmacy fulfillment to consumer brands, which then set their own prices and pocket the margin. So the cost you eventually pay depends entirely on whichever brand is sitting on top of Beluga's plumbing, not on Beluga itself. Some of those brands run aggressive teaser pricing; others charge well over a thousand dollars a month. There is no way to quote a single figure here, and you should confirm pricing with whatever consumer brand you actually land on before you hand over a card.

What it powers: compounded GLP-1s through outside pharmacies

On the weight-loss side, Beluga supports compounded semaglutide and tirzepatide, with clinicians handling the dose titration and the medication dispensed through independent pharmacies such as CareGLP and Belmar. A few things are worth being clear-eyed about. These are compounded formulations, not the FDA-approved branded pens like Wegovy or Zepbound, so the usual compounding caveats apply. The pharmacies it works with follow FDA and USP standards and run third-party batch testing, which is a real plus, but the actual patient experience still rides on the consumer brand using the platform.

The turnkey infrastructure is the real differentiator

What genuinely sets Beluga apart is that it is one of the rails the whole DTC GLP-1 boom runs on. Its homepage frames the offering as four building blocks a brand can switch on: ecommerce, a physician network, pharmacy fulfillment, and a legal framework. The company carries serious operational credentials for that role:

• A board-certified provider network with 50-state medical coverage
• LegitScript certified, plus SOC 2 and ISO 27001 security posture
• Partner pharmacies following FDA/USP standards with third-party batch testing
• A complete turnkey stack so a brand can launch GLP-1 telehealth without building its own clinical and pharmacy operations

For an entrepreneur, that is a compelling package. For a patient, it is mostly invisible plumbing whose quality you experience secondhand.

Who Beluga is actually for

This one is genuinely for brands launching a DTC GLP-1 telehealth offering who want a compliant, ready-made backbone rather than a startup-from-scratch headache. If that is you, Beluga is a serious candidate. If you are an individual just trying to lose weight, you cannot really buy from Beluga directly, and you would instead end up with one of its downstream consumer brands, whose care quality and pricing vary widely. In that case, you are better served comparing the consumer-facing providers on our list head to head using our scoring methodology.

Trust, oversight, and the FDA-scrutiny footnote

On paper the oversight signals are solid: board-certified clinicians, LegitScript certification, recognized security standards, and tested compounded product. We did not find any direct FDA warning letter issued to Beluga itself. But honesty requires the footnote: Beluga has been named in coverage of the broader FDA scrutiny around how nationwide telehealth groups market compounded GLP-1s. That is industry-wide heat rather than a specific enforcement action against this company, and we have left its FDA-warning record empty on that basis, but it is context worth knowing before you trust a brand built on this platform.

The honest drawbacks

• It is a white-label B2B group, not a service an individual can sign up with directly
• It supports compounded GLP-1s, not FDA-approved branded medications
• There is no public consumer price to evaluate
• It has been cited in coverage of FDA telehealth GLP-1 marketing scrutiny
• Your actual care quality depends on whichever consumer brand is using the platform

Bottom line

Beluga Health is a credible, credential-heavy backbone for the GLP-1 telehealth industry rather than a place you personally fill a prescription. If you run a brand and want compliant, turnkey infrastructure with board-certified providers and tested compounded medication, it earns a real look. If you are a patient, treat Beluga as useful background for understanding who is really behind the brand you are considering, then shop the consumer-facing providers directly so you can actually see the price, the pharmacy, and the support you will get.

For a side-by-side, Sesame Care ($59/month) and bmiMD ($99/month) are the most comparable options to weigh against Beluga Health.